📉 Trial curve calculator
Type a starting weight. We apply the average change from each molecule's main trial.
Semaglutide1 receptor · STEP 1 · 68 weeks
Tirzepatide 🥈2 receptors · SURMOUNT-1 · 72 weeks
Retatrutide 🥇3 receptors · phase 2 · 48 weeks
Averages at the top studied dose in supervised trial participants. Individual results in those trials ranged widely. This is arithmetic on published averages, not a prediction for you.
🏆 Top pick
Triple agonistVial
GLP-3RT Vial
★★★★★4.8/5 editorial scoreThe compound behind the biggest weight-trial numbers of the decade. Three receptors, one molecule, 13 lots with a COA on file.
from $100.00
💰 Best value
Dual agonistVial
GLP-2T Vial
★★★★★4.7/5 editorial scoreThe dual-agonist molecule with the deepest published record: 72-week data, a head-to-head win and the lowest price per mg in the catalog.
from $76.00
⚠️ Research use only. These compounds are sold for laboratory research and are not FDA-approved medicines. Trial figures on this page describe the pharmaceutical molecules studied under medical supervision.